Envoy Medical, Inc. (COCHW) stock
COCHWNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31Also trades as COCH
$0.03−0.00 (-15.49%)
Close on Oct 30, 2026Market cap $511.80MP/E –Yield –
Envoy Medical revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Envoy Medical's revenue for the twelve months ending Jun 30, 2026 was $207.00K, down 6.8% year over year. For fiscal 2025 it was $241.00K, up 7.1% from the year before.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $241.00K | +7.1% |
| FY2024 | Dec 31, 2024 | $225.00K | -28.8% |
| FY2023 | Dec 31, 2023 | $316.00K | +33.3% |
| FY2022 | Dec 31, 2022 | $237.00K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $51.00K | -34.6% |
| Q1 FY2026 | Mar 31, 2026 | $39.00K | -15.2% |
| Q4 FY2025 | Dec 31, 2025 | $75.00K | +78.6% |
| Q3 FY2025 | Sep 30, 2025 | $42.00K | -25.0% |
| Q2 FY2025 | Jun 30, 2025 | $78.00K | +14.7% |
| Q1 FY2025 | Mar 31, 2025 | $46.00K | -22.0% |
| Q4 FY2024 | Dec 31, 2024 | $42.00K | -55.8% |
| Q3 FY2024 | Sep 30, 2024 | $56.00K | -30.0% |
| Q2 FY2024 | Jun 30, 2024 | $68.00K | +7.9% |
| Q1 FY2024 | Mar 31, 2024 | $59.00K | -24.4% |
| Q4 FY2023 | Dec 31, 2023 | $95.00K | +375.0% |
| Q3 FY2023 | Sep 30, 2023 | $80.00K | +40.4% |
| Q2 FY2023 | Jun 30, 2023 | $63.00K | – |
| Q1 FY2023 | Mar 31, 2023 | $78.00K | – |
| Q4 FY2022 | Dec 31, 2022 | $20.00K | – |
| Q3 FY2022 | Sep 30, 2022 | $57.00K | – |